An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
The asymmetric unit of the title compound, C10H11ClN2O, contains two molecules. The non-H atoms of each molecule lie approximately on a plane (r.m.s. deviations = 0.062 and 0.110 Å), and the C=N double bond has a Z-configuration in both independent molecules. In the crystal, adjacent molecules are linked by N—H⋯Ocarbonyl hydrogen bonds, forming chains running along [100].
A cubic-like nanostructured SnO<sub>2</sub>–Co<sub>3</sub>O<sub>4</sub>hybrid was sonochemically synthesized<italic>via</italic>CoSn(OH)<sub>6</sub>nanocubes as an intermediate for supercapacitor application.
Poly(propylene carbonate)/ β ‐cyclodextrin (PPC‐BCD) nanocomposites were developed as effective extractor for a specific extraction and separation of cadmium(II) by use of inductively coupled plasma‐optical emission spectrometry. The selectivity of nanocomposites with different wt% of BCD (PPC‐BCD 0.5, PPC‐BCD 1, PPC‐BCD 3, PPC‐BCD 5, or PPC‐BCD 10) was investigated toward Cd(II). Based on selectivity and pH studies, Cd(II) was the most quantitatively adsorbed on PPC‐BCD 5 phase at pH 6, indicating that PPC‐BCD 5 was the most selective toward Cd(II) among other nanocomposites. On the basis of adsorption isotherm study, the superior adsorption capacity of PPC‐BCD 5 phase for Cd(II) was found to be 149.25 mg·g −1 , following the Langmuir adsorption isotherm model. The kinetic of adsorption for Cd(II) has been examined by pseudo‐first‐ and second‐order models. The kinetic exploration suggested a pseudo‐second‐order kinetic model for the adsorption of Cd(II) on the PPC‐BCD 5. Additionally, results of thermodynamic investigation demonstrated favorable spontaneous process for the adsorption mechanism of PPC‐BCD 5 toward Cd(II).
An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
The mol-ecule of the title compound, C(20)H(19)ClN(4)O(4)S, features a central pyrazole ring that possesses a benzene substituent, as well as a conjugated =C-C=C-C(meth-yl) substituent. The benzene ring is slightly twisted [dihedral angle = 7.7 (2)°] with respect to the five-membered ring; the mean plane of the zigzag =C-C=C-C fragment [torsion angle = 178.0 (4)°] is also slightly twisted [dihedral angle = 10.6 (4)°]. The amine and hy-droxy groups form intra-molecular hydrogen bonds. The amide group uses one of its H atoms to form a hydrogen bond to the sulfamyl O atom of an inversion-related mol-ecule. Adjacent dimers are further linked by an N-H(amido)⋯N(pyrazole) hydrogen bond to generate a linear chain. The crystal studied is a nonmerohedral twin with a minor twin component of 25.6 (2)%.
Tigecycline is a broad-spectrum antibiotic effective against multidrug-resistant MDR pathogens particularly in complicated intra-abdominal infections cIAIs and complicated skin and soft tissue infections cSSTIs. It is active against methicillin-resistant Staphylococcus aureus MRSA vancomycin-resistant enterococci VRE and extended spectrum beta-lactamase ESBL-producing Gram-negative bacteria. However it has limitations against intrinsically resistant organisms such as Pseudomonas aeruginosa Acinetobacter baumannii and carbapenem-resistant Klebsiella pneumoniae. The pharmacokinetics of tigecycline restricts its use in blood stream infections BSIs and pneumonia. Nevertheless combination therapy with colistin or carbapenems has been shown to improve outcomes in patients with BSIs. High-dose tigecycline regimens enhance efficacy but are associated with risk of adverse effects. Its role in stewardship programs is vital however the potential for resistance development necessitates judicious use preference for combination regimens and robust infection control measures.